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Abstract
Glutathione peroxidase (GPx) is a selenoprotein with biological properties that 
allow the detoxification of endogenous or exogenous reactive oxygen species as well 
as the elimination of xenobiotic compounds in the cells. Due to its isoform activities 
and pathophysiological functions, GPx holds the status of a redox system (GSH/
GSSG) in the glutathione (GSH) system to prevent oxidative damage of cellular 
constituents. As such, the GPx is the first line of defense against free radicals. Its 
deficiency causes oxidative stress that not only promotes the oxidation of proteins 
and deoxyribonucleic acid (DNA) but also leads to insulin resistance, dyslipidemia, 
inflammation, and metabolic alterations, which expose to high risk for cardiometa-
bolic disorders due to cardiovascular and degenerative diseases especially when 
associated with aging. This work presents a review of different studies done on the 
localization of GPx in subcellular organelles, activity changes during cellular aging, 
their effects on cardiometabolic risks, and associated diseases.
Keywords: aging, antioxidants, cardiometabolic risks, disease, free radicals, 
glutathione, glutathione peroxidase, selenium, traditional foods
1. Introduction
Cardiometabolic risks (CMR), the main causes of the onset of cardiovascular 
diseases (CVDs), insulin resistance (IR), dyslipidemia, and systemic inflammation 
are among the major metabolic alterations caused largely by oxidative stress. The 
oxidative stress is the result of the imbalance of the antioxidant system in favor 
of prooxidants, which interferes with the GSH/GSSG system in the antioxidant 
defense and the regulation of gene expression, the synthesis of DNA and proteins, 
cell proliferation and apoptosis, and cytokine production and protein glutathionyl-
ation, due to alteration of certain cellular functions. In this system, the deficiency of 
GPx, as a first line of defense against free radicals, stimulates oxidative stress, which 
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promotes the development of chronic noncommunicable diseases (NCDs), such 
as CVDs, as well as early aging and cancer [1]. Having sufficient knowledge of the 
GSH system and the regulation and functions of GPx is essential to prevent meta-
bolic alterations and to develop effective strategies for treating these diseases. This 
chapter reviews (i) the main scientific information on GPxs and the GSH system 
and their location in subcellular organelles and changes during aging; (ii) the link 
between oxidative stress, GPxs, and the metabolic syndrome; and (iii) the effects 
of GPxs in chronic pathogenesis and CVDs in particular and the role of dietary 
selenium (Se) in GPx activities.
2. Glutathione system
2.1 Structure and functions of the glutathione system
Glutathione, γ-glutamyl-cysteinyl-glycine (GSH), is a ubiquitous intracel-
lular tripeptide present in all mammalian tissues, especially in the liver. This 
thiol-containing molecule is an important antioxidant in cell compartments with 
high concentrations in cytosol (1–11 mM), nuclei (3–15 mM), and mitochondria 
(5–11 mM). GSH represents a significant part of the redox status of thiol mam-
malian systems [2, 3]. It should be noted that the research on GSH metabolites was 
done in vivo more than a century before [4].
GSH has several biological functions including the detoxification of electro-
philes, the antioxidant defense, the maintenance of the thiol status of proteins, and 
the modulation of DNA synthesis and the immune system [4]. Additionally, GSH 
serves as a cysteine reservoir with a proton-donating sulfhydryl function, which 
allows GSH to act as an antioxidant. In its role as an antioxidant, GSH effectively 
removes free radicals and other reactive oxygen species through the GPx activity 
[5], which oxidizes GSH to GSSG, and the action of NADPH-dependent glutathi-
one reductase, which generates GSH [3]. In the presence of GSH, glutathione-S-
transferase activity detoxifies xenobiotics and various physiological metabolites 
to form mercapturates and reactivated glucose-6-phosphate dehydrogenase [6]. 
With NO, GSH is necessary for the hepatic action of insulin sensitizing agents and 
plays a crucial role in regulating the redox state of the cell with lipids, glucose, and 
amino acids. Besides to its antioxidant nature, GSH is involved in the transfer of 
amino acids by the gamma-glutamyl cycle as well as in the hormonal metabolism of 
estrogen, leukotrienes, prostaglandins and as a transduction signal for transcription 
[3]. In the central nervous system (CNS), GSH functions include maintenance of 
neurotransmitters, membrane protection, detoxification, metabolic regulation, and 
modulation of signal transduction. The depletion of GSH in the brain is implicated 
in both Parkinson’s disease and neuronal damage after stroke [7].
2.2 Regulation of glutathione metabolism
Glutathione is synthesized in the cytosol of all animal cells by the regulated 
action of gamma-glutamate cysteine ligase (γ-GCL), glutathione synthetase, glu-
tathione reductase (GSR), and gamma-glutamyl transpeptidase (γ-GGT) and from 
which it is distributed to the other cellular compartments [8]. The key transcription 
factors that regulate gene expression are NF-E2-related factor 2 (Nrf2) via the 
antioxidant response element (ARE), AP-1, and nuclear factor kappa B (NF-κB). 
The alteration of the GSH concentration affects the dysregulation of cell prolifera-
tion and the transcription of detoxification enzymes and apoptosis [9]. Therefore, 
de novo synthesis of GSH is essential for the adaptive response to oxidative stress. 
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Intracellular GSH homeostasis is regulated not only by de novo synthesis but 
also by several factors, including its use and recycling in cells [3]. A disruption 
of GSH homeostasis could induce oxidative stress and lead to neurodegenerative 
diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, Alzheimer’s 
disease, and dementia, with impaired motor and cognitive functions [7]. There 
is also increasing evidence that deregulation of GSH synthesis contributes to the 
pathogenesis of diseases such as diabetes mellitus, pulmonary and hepatic fibrosis, 
alcoholic liver disease, cholestatic liver injury, endotoxemia, and drug-resistant 
tumors cells [10]. GSH also modulates cell death whether it is apoptosis or necrosis. 
In both cases, GSH levels influence the expression/activity of caspases and other 
important signaling molecules in cell death. The regulation of GSH is well reported 
by Lu [11], and its role is illustrated in Figure 1.
3. GPx, oxidative stress and cardiometabolic risk
GPx is the most powerful biological antioxidant reducer. The GSH/GSSG ratio 
of GSH, as well as other active redox couples, including NADP/NADPH and FAD/ 
FADH2, regulates and maintains cellular redox status. Under normal conditions, 
antioxidant systems neutralize ROS. However, when the ROS level is high metabolic 
alterations of cellular constituents occurs related to oxidative damage to the cells 
[6, 10]. When there is a prolonged increase in oxygen reactive species (ROS) levels 
that the existing antioxidant potential cannot eliminate, cell enters in the state of 
chronic oxidative stress. This leads to insulin resistance (IR), atherogenic dyslip-
idemia, visceral obesity, and pro-inflammatory and pro-thrombotic status. These 
are potential factors that increase cardiometabolic risks (CMRSs) and may lead to 
or accompany some pathologies, such as diabetes mellitus, cardiovascular disease, 
neurodegenerative, cancer, and aging diseases [12].
The GSH redox cycle is a major source of protection against mild oxidative 
stress with the GPx, antioxidant enzyme that oxidizes GSH to GSSG to protect 
cells against the proliferation of reactive oxygen species (ROS) or reactive nitrogen 
species (RNS), sparing them from oxidative damage, while catalase is becoming 
increasingly important in protecting against severe oxidative stress [3, 6, 10]. The 
Figure 1. 
Glutathione system with synthesis routes and pentose phosphates: the enzymes that catalyze the reactions are 
(1) GPxs, (2) superoxide dismutase, (3) NADPH oxidase and mitochondrial respiratory complexes, (4) 
glutathione reductase, (5) gluco-6-phosphate dehydrogenase, (6) γ-glutamyl transpeptidase, (7) γ-glutamyl 
cyclotransferase, (8) γ-glutamylcysteine synthetase, (9) glutathione synthetase, (10) γ-glutamyl transpeptidase. 
Abbreviations: AA, amino acid; O2
−, radical superoxide; H2O2: hydrogen peroxide; GS-NO, glutathione-nitric 
oxide adduct; LOH, alcohol lipid; LOOH, hydroperoxide lipid, R., radical; RH, nonradical; X, electrophilic 
xenobiotics.
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variation in the erythrocyte GSH system without nuclear capacity to restore homeo-
stasis may be an early biomarker of chronic oxidative stress that could be a first step 
in the development of cardiometabolic complications. If the cells are overwhelmed 
by the intensity of the oxidative stress, they die by necrosis or apoptosis [13].
It has also been reported that obese women with high GPx activity have an 
altered cardiometabolic profile, evidenced by insulin resistance predominantly 
affecting the liver, altered carbohydrate and lipid metabolisms, and a larger wall 
thickness of blood vessels than those with lower GPx activity. This suggests that 
GPx blood activity may be a parameter contributing to the identification of sub-
clinical asymptomatic cardiometabolic disorders [14].
4.  Subcellular localization of GPx and change of the glutathione system 
during aging
In view of its role in the regulation of the cellular redox status, GSH has specific 
vital functions within the intracellular organelles where it is located. GSH is gener-
ally in the greatly reduced state in the different cellular compartments. The integ-
rity of cell and subcellular membranes is highly dependent on the presence of GSH 
and GPx [15]. Decreased GSH levels in some organelles and tissues during aging 
expose cells to an increased risk of succumbing to stress. Moderate stress increases 
glutathione levels to protect cells against more severe stress. In the cytoplasm, 
the oxidized form (GSSG) is usually in the order of at least about 1% of the total. 
In the nucleus, GSH maintains the redox status of the sulfhydryl groups of the 
proteins involved in nucleic acid biosynthesis and DNA repair. It is also used in the 
reduction of ribonucleotides to produce deoxyribonucleotides by ribonucleotide 
reductase [16]. A significant portion of ER glutathione is oxidized, with a [GSH]/
[GSSG] ratio that can reach 3:1. This relatively oxidative thiol-disulfide medium 
is essential for the oxidative folding of nascent proteins in ER. Mitochondria 
contain 10–15% of cellular GSH, but being of a very small volume, the local 
concentration of GSH in these organelles is generally great and 85–90% in the 
cytosol. Studies have shown that there is a close relationship between the survival 
of the mitochondrial GSH pool (mGSH) and that of the cells due to the central 
role of mitochondria in programmed cell death (apoptosis) as well as important 
involvement of ROS produced at 90% in mitochondria [17]. High levels of ROS 
and calcium, acting together, can trigger the mechanism of cell death via apoptosis 
or necrosis. Thus, the decrease in mGSH levels is closely associated with certain 
pathologies in both humans and animals. Differential centrifugation and isopycnic 
equilibration in WI-38 fibroblast density gradients allowed for GSH localization in 
all subcellular fractions, whereas glutathione peroxidase and reductase activities 
were restricted to cytoplasm and mitochondrial fractions. The evolution of GSH 
in aging fibroblasts showed a sudden increase in its concentration just before cell 
death, whereas GPx activity was already decreasing at the beginning of passages, 
and that of glutathione reductase was constant and reaching a very low level at the 
end of the cell culture, suggesting that the GSH system was probably involved in 
cell degeneration associated with aging [18].
Glutathione peroxidase (EC 1.11.1.9 and EC 1.11.1.12) is a superfamily of 
proteins found in many living organisms. It consists of four subunits generally 
containing a Se atom incorporated in the form of selenocysteine (Sec), which is 
recognized today as the twenty-first amino acid, the first major enzyme identified 
as an intracellular antioxidant. In animal cells, and in particular in human eryth-
rocytes, GPx is the main antioxidant enzyme for detoxification hydrogen peroxide 
(H2O2) [17]. It is dependent on Se; the deficiency of which is associated with the 
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risk of contracting several diseases, notably cancer. GPxs that use GSH to catalyze 
the reduction of H2O2 and lipid peroxides have been identified. Some GPxs are 
therefore dependent on Se and use GSH as a reducing agent, while others, called 
TGPx, do not contain Se (NS-GPx) and reduce ROS using thioredoxin, which 
acts as ROS sensors in various pathways and signal transduction. Catalysis of GPx 
is essentially following three distinct redox modifications of the Se at the center 
of the active site, in a triad of selenocysteine, glutamine, and tryptophan, which 
reduces GSH to GSSG [14, 19].
The study on the evolution of the gene family of GPxs suggests that classes 
of basal peroxidase glutathione originate from independent evolutionary 
events such as gene duplication, gene loss, and lateral transfer of genes between 
invertebrates and vertebrates or plants. This evolution of the family of the GPx 
gene as a whole has been described by Deponte and Margis et al. [20, 21]. The 
mammalian GPx family is divided into six clades according to their amino acid 
sequence, substrate, specificity, and subcellular localization. Other studies 
have revealed other GPx containing as peroxidic site the residue of cysteine. 
These include the GPx7 and GPx8, which are isoforms of endoplasmic reticulum 
sulfhydryl peroxidases.
As a reminder, in humans, eight different isoforms of GPx (GPx1–8), which use 
GSH to catalyze the reduction of hydrogen peroxide and lipid peroxides, have been 
identified [19, 20]: GPx1, GPx2, GPx3, GPx4, and GPx6, which contain a selenocys-
teine residue (SeCys) and the GPx5, GPx7, and GPx8 that do not contain SeCys but 
contain a Cys residue. Noteworthy, GPx1, GPx2, GPx4, GPx5, GPx6, and GPx7 are 
tetramers, while GPx3 is monomeric and GPx8 is dimeric [20, 22, 23]. The follow-
ing paragraphs briefly provide an overview of each of the eight types of GPx.
• Glutathione peroxidase 1 (glutathione: H2O2 oxidoreductase, EC 1.11.1.9, 
GPx1 or cGPx) is abundant in the cytoplasm of almost all mammalian tissues. 
Its gene is characterized by the Pro198Leu polymorphism and a number of 
leucine-repeated alanine (A7L) codons, which are associated with the risk of 
cancer and type 2 diabetes. GPx1 prevents oxidative damage, lipid peroxida-
tion, and protein degradation induced by cytotoxic peroxides. GSH cytosolic 
and mitochondrial peroxidases only reduce soluble hydroperoxides, such 
as H2O2 and some organic hydroperoxides, such as hydroperoxy fatty acids, 
cumenehydro peroxide, or t-butyl hydroperoxide. Increased activity of GPx1 
inhibits hydroperoxide-induced apoptosis. GPx1 and phospholipid hydroper-
oxide glutathione peroxidase GPx4 (or PHGPx) are found in most tissues [17, 
19]. A study of the subcellular localization of GPx1 variants to appreciate the 
molecular consequences associated with diseases demonstrated that the pri-
mary sequence of GPx1 affects subcellular localization and that the sequence 
and cell location can be important to understand the impact of GPx1 on human 
diseases, including cancer [24].
• Glutathione peroxidase 2 (GPx2 or GI-GPx) is extracellular and important as 
a barrier against the absorption of hydroperoxide in the gastrointestinal tract. 
GPx2 could be an anti-inflammatory and anticarcinogenic enzyme [25].
• Glutathione peroxidase 3 (GPx3 or pGPx) is excreted from various tissues in 
contact with body fluids and is particularly abundant in plasma. It reduces 
hydroperoxides of phospholipids and contributes to extracellular antioxidant 
status in humans. Low levels of GPx3 increase the risk of cardiovascular 
events in patients with a trial fibrillation and in the elderly. GPx3 is directed to 
extracellular compartments [23].
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• GPx4 or PHGPx is located in the cytosol and membrane fraction. It reduces 
more complex lipids such as phosphatidylcholine hydroperoxides, fatty acid 
hydroperoxides, and cholesterol [26]. GPx4 shares the amino acid motif of 
selenocysteine, glutamine, and tryptophan (catalytic triad) with other GPxs. 
Its inactivation causes an accumulation of lipid peroxides, resulting in the 
death of ferroptotic cells and mutations causing spondylometaphyseal dys-
plasia [27]. In mice and rats, three distinct GPx4 isoforms, cytosolic GPx4, 
mitochondrial GPx4 (mGPx4), and nuclear GPx4 (nGPx4), were identified 
with different functions. Cytosolic GPx4 is essential for embryonic develop-
ment and cell survival. Both mGPx4 and nGPx4 are involved in spermatogen-
esis and male fertility. GPx4 has been shown to be a more attractive candidate 
for silencing lipooxygenases and influencing cytokine signaling [27].
• Glutathione peroxidase (GPx5) does not contain Sec or Se; it is specifically 
expressed in the epididymis of the male reproductive tract in mammals and is 
regulated by androgens. It plays a role in the protection of sperm membranes 
against the harmful effects of lipid peroxidation and/or in preventing the 
premature reaction of the acrosome [21].
• Glutathione peroxidase 6 (GPx6) is a selenocysteine close to GPx3 whose expres-
sion of its gene is limited to embryos and adult olfactory epithelium [19, 21].
• Glutathione peroxidase 7 (GPx7) is an endoplasmic reticulum (ER) monomer 
containing a Cys redox center (CysGPx). It catalyzes the peroxidase cycle 
through a Cys mechanism in which GSH and protein disulfide isomerases,are 
alternative substrates, allowing rapid reactivity with thioredoxin (Trx) or 
proteins related to most other CysGPx. It protects esophageal epithelia and 
breast cancer cells from oxidative stress [19].
• Glutathione peroxidase 8 (GPx8) is a resident endoplasmic reticulum (ER) 
protein that introduces disulfide bonds into nascent proteins via protein disul-
fide isomerase (PDI); it is a PDI peroxidase that reduces the H2O2 content and 
oxidative stress in emergency rooms [21]. In the presence of peroxide, GPx7 
and GPx8 interact by oxidation for the folding of disulfide-forming proteins.
5. Metabolic regulation of glutathione peroxidase
Many studies on the metabolic regulation of GPx have been focused on GPx1, 
a selenocysteine-dependent enzyme (Sec). The latter is encoded by UGA and 
directed by the selenocysteine insertion sequence, SECIS element [28, 29], which 
serves as a platform for the recruitment of elongation factors of selenocysteine-
tRNA[Ser]Sec (Sec-tRNA [Ser] Sec) translation that decodes the UGA codon for the 
whole family of selenoproteins. The exogenous Se supply controls the enzymatic 
activity of human GPx1 without affecting the level of GPx1 mRNA, suggesting that 
the human GPx1 gene is posttranscriptionally regulated by Se [30].
GPx1 is induced by etoposide, topoisomerase II inhibitor, apoptosis inducer, 
and p53 activator, which positively regulates a promoter element upstream of the 
GPx1 gene. This transactivation of GPx1 by p53 bonds is the p53 signaling pathway 
to the antioxidant pathway. In addition, analysis of p53-induced apoptosis in a 
human colon cancer cell line showed that elevated p53 expression was associated 
with an elevation of GPx1 [31, 32]. Studies have shown that in the skeletal muscle of 
severely dyslipidemic transgenic mice and in a pro-oxidative and pro-inflammatory 
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state, GPx1 is hypermethylated, which decreases GPx1 expression and weakens the 
endogenous antioxidant defense. The chronic physical exercise allowed increasing 
the expression of GPx1 in connection with a transient hypomethylation of its gene. 
The epigenetic regulation of the expression of GPx1 is therefore a function of the 
methylation of its coding gene [32]. As part of this review, we report knowledge on 
regulatory factors, the link between the regulation of the mRNA and the expression 
of GPx activity, the relationship between abnormal expression of GPx1 and the 
ethology of diseases, and finally the roles of GPx in different diseases especially in 
chronic diseases.
In addition to Se as the main regulator of GPx1 expression, the factors associat-
ing the selenocysteine insertion sequence (SECIS), adenosine [33], c-Abl and Arg 
tyrosine kinase receptors, and epidermal growth factor influence gene expression 
of GPx1 and affect the functional coordination between GPx1 and other seleno-
proteins or antioxidant enzymes in various metabolic circumstances. It will also 
be interesting to know how these regulators affect the functional coordination 
between GPx1 and other selenoproteins or antioxidant enzymes in various meta-
bolic circumstances [34]. Se is the main regulator of GPx1 expression. Lower levels 
of Se cause a decrease in GPx activity [35], increasing the damage caused by free 
radicals, which contribute to aging and mortality in adults over 65 [36, 37]. In the 
cells, Se deficiency results in a 60% reduction in GPx1 mRNA and a 93% loss of 
GPx1 activity. The injection of dietary Se allows rapid recovery of a saturable activ-
ity of GPx1. Of these facts, GPx1 was used as a biomarker for assessing body status 
in Se or Se nutritional status requirement; it is also considered a place of storage 
of Se for the regulation of the expression of selenoprotein [38, 39]. Se reduces the 
incidence of aberrant preneoplastic colon cancer and crypt foci in animal models 
[40]. He has also been involved in the possible chemoprevention of certain cancers 
[41]. Using a mouse TGFα/c-Myc model of cancer, Novoselov et al. suggested that 
selenoproteins and Se compounds contributed to the inhibition of liver carcinogen-
esis. Although GPx1 is unlikely to be the only selenoprotein involved, these results 
have suggested the involvement of GPx1 in chemotherapy prevention conferred by 
the food Se [42].
The SECIS selenocysteine (sec) insertion sequence represents mRNA and serves 
as a platform for the recruitment of Sec -ARNt translation stretching factors that 
decode the UGA codon for the incorporation of Se into selenoproteins [43]. The 
SECIS association factors regulate the expression of selenoprotein by displace-
ment of SECIS-binding protein 2 (SBP2), which specifically binds SECIS to dry EF 
elongation factor with specificity for selenocysteyl-tRNA (Sec-tRNA[Ser] Sec). TRNA 
(Ser) SECIS is aminoacylated with serine which is then converted to intracellular 
Sec [44] from cytoplasm to nucleus in case of exposure to ROS or depending on 
Se status that modulates Sec-tRNA[Ser] Sec with methylation of Sec in position [45], 
which modifies the secondary and tertiary structure of Sec-tRNA [Ser] Sec. It is for 
this reason that the expression of GPx1 and GPx3 is highly reactive to the deficiency 
in Se. The basic mechanisms of the synthesis and insertion of Sec in proteins, their 
characterization, the molecular and physiological functions of selenoproteins, and 
their roles in human health were reviewed by Vyacheslav [46].
Adenosine is a powerful and independent regulator of GPx expression; it 
attenuates damaging effects of ROS in the cells and improves the stability of the 
mRNA [47]. The non-receptor c-Abl and Arg tyrosine kinases represent another 
Se-independent regulator for GPx1 expression. They are activated in the response 
to ROS and involved in the apoptotic response to oxidative stress. C-Abl and Arg 
combine, and their interaction is regulated by the intracellular level of oxidants. 
GPx1 functions as a substrate for c-Abl- and Arg-mediated phosphorylations 
in Tyr-96, which induces its activity. Loss of GPx1 regulation by c-Abl and Arg 
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increases the susceptibility to ROS induced by apoptosis [48]. NF-κB is a transcrip-
tion factor involved in the regulation of cellular responses to a variety of environ-
mental stressors [49]. Recent evidence has suggested that GPx1 and c-Src tyrosine 
kinases participate in the phosphorylation of IκBα which, in response to hypoxia, 
leads to the activation of NF-κB elevated in hydrogen peroxide-treated embryonic 
fibroblasts [50]. GPxs modulate the activation of NF-κB inhibitors by cyclooxy-
genases and lipooxygenases, the activation which depends on hydroperoxide. It 
also neutralizes hydroperoxide effects, such as cytokine signal and apoptosis, and 
also has an important role in the human immunodeficiency virus (HIV) infection. 
The mitogen-activated protein kinase p38 (MAPK) and c-Jun N-terminal kinase 
(JNK) transmit essential information in ROS-induced apoptosis [51]. GPx1 (−/−) 
mouse fibroblasts showed a decrease in protein kinase B (Akt) phosphorylation at 
Ser-473 during stimulation with hydrogen peroxide, while GPx1-under-expressed 
MCF-7 cells did not affect the expression and phosphorylation of p38 MAPK [52]. 
Homocysteine, a risk factor for cardiovascular disease, interferes with the transla-
tional reading of SECIS in the expression of GPx1 [53] and, therefore, inhibits the 
expression of GPx1 promoting the increase of oxygen species reagents that inacti-
vate nitric oxide and cause endothelial dysfunction.
6. Physiopathological functions of GPx and associated diseases
The increase of ROS has been associated with the appearance and progression of 
aging and related diseases including arthritis, diabetes, dementia, cancer, athero-
sclerosis, and vascular diseases, which are inflammatory disorders, a consequence 
of oxidative stress [54, 55]. In reproductive medicine, free radicals cause fragmenta-
tion of spermatozoa in humans or the occurrence of ovarian failure in women, thus 
reducing the mobility of spermatozoa and their ability to fertilize especially in the 
elderly [56]. Deficiency of GPx results in direct tissue damage and activation of age-
related NF-κB inflammatory pathways [57]. The application of over-expressing or 
knock-out and transgenic GPx1 mouse models overwhelming in vivo evidence for 
the protective role of GPx1 against oxidative injury and death induced by ROS and 
RNS. Also, the impairment of GPx1 expression is associated with the etiology of a 
number of chronic diseases, including cancer, cardiovascular diseases, autoimmune 
diseases, and diabetes [19, 27].
6.1 Diabetes
Type I diabetes, Type II DM, and gestational diabetes are characterized by 
hyperglycemia, dyslipidemia, and insulin resistance, which increase oxidative 
stress and activate the protein kinase C (PKC) as well as the receptor for advanced 
product glycation (AGE) and low levels of antioxidants and GPx in diabetic 
patients. GSH is a constituent of blood plasma. It has been found that in normal 
subjects, GSH plays an important role in controlling the production of free radicals, 
but in the case of diabetes mellitus, there is abnormal generation and elimination of 
plasma GSH [58]. In fact, diabetes induces an alteration in the activity of glutathi-
one peroxidase and reductase to maintain a normal GSH level in order to avoid the 
increase of nitric oxide and the risk of thrombosis. However, the free radicals may 
play a pathogenic role in the pathophysiology of the response of glucose in β-cells 
and in the genesis of chronic complications. Mitochondria, the main source of ROS 
production, contribute to the complications of diabetes [19]. Insulin resistance, 
associated with mitochondrial dysfunction and increased production of ROS, 
alters the cardiovascular, renal, and neural functions of insulin and is a risk factor 
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for microvascular disease. It should also be noted that ROS generates a metabolic 
syndrome due to changes in energy metabolism, activation of RNS, xanthine 
oxidase, increased expression of inflammatory mediators, and low levels of GPx 
and other antioxidant enzymes. Their increase induces endothelial lesions and 
the oxidation of LDL and redox-sensitive genes, reaching the monocyte-1 chemo 
attracting protein and the vascular cell adhesion molecules, molecular mechanisms 
that are involved in the development of the atherosclerosis. Under these conditions, 
it is likely that ROS and RNS contribute to the destruction of pancreatic β-cells dur-
ing type diabetes. Increased levels of saturated fatty acids (FFA) and glucose in the 
blood are considered to be major mediators of signals that bind β-cells to apoptosis 
and death for T2 DM. The ER-resident GPx7 or GPx8 isoforms protect β-cells of 
insulin-secreting INS against lipotoxicity by enhancing the antioxidant capacity of 
ER without compromising insulin production and oxidative protein folding mecha-
nisms [19, 59]. Presumably, oxidative stress is involved in the pathogenesis and 
complications associated with all three types of DM, and GPx1 plays a critical role 
in the regulation of oxidative stress [60].
6.2 GPx and obesity
Obesity promotes the storage of triglycerides in adipose tissue. Firstly, adipose 
tissue produces interleukin-6 (IL-6) that stimulates the absorption of dopamine 
creating a feeling of satiety, which has a direct effect on weight control. Tumor 
necrosis factor-α (NF-α) activates the NF-κB, which promotes the adhesion to the 
surface of endothelial and vascular smooth muscle cells of molecules causing an 
inflammatory state of adipose tissue, dysfunction of the endothelium, and finally, 
atherogenesis [61]. With the production of adipokines and decreased activity of 
GPx and antioxidant capacity, the endothelium becomes deficient in nitric oxide 
(NO), a vasodilator, and thus promotes atherosclerotic diseases. Secondly, the low 
level of serum GPx in obese patients and the low-serum Se concentrations, associ-
ated with the onset of signs of metabolic syndrome, may be related to the presence 
of a predisposing state to atherosclerosis manifested by increased consumption of 
antioxidants by radical interaction [19, 62].
6.3 Cardiovascular diseases
Cardiovascular diseases (CVDs) are also characterized by insulin resistance, a 
pro-oxidative and pro-inflammatory state, as well as a dysregulation of the expres-
sion of various factors responsible for the homeostasis of redox and inflammatory 
environment [62]. This is a result of oxidative stress, because plasma total GSH 
content is low in patients with cardiovascular disease.
High levels of homocysteine, with the slowing of GPx1 blood vessel activity, 
promote a higher concentration of intracellular peroxides that enhances oxidative 
stress and causes damage to endothelial cells in the pathogenesis of atherogenesis. 
Homocysteine probably interrupts UGA reading so that GPx1 expression is down-
regulated [53].
Studies on the evaluation of the association between GPx1 and atherosclerosis 
variants in Japanese patients with type 2 diabetes, with four polymorphisms, 
reported that functional variants of the GPx1 gene are associated with increased 
mean intima-media (IMT) thickness of carotid arteries and cardiovascular risk and 
peripheral vascular disease in type 2 diabetics [63]. These results suggest that GPx1 
protects against atherogenesis in blood vessels and virus-induced myocarditis by 
reducing ROS levels. Disturbances in GSH metabolism may explain an increase in 
blood pressure related to age [64]. Selenoprotein polymorphisms are a risk factor 
Glutathione Peroxidase in Health and Disease
10
for the development of systolic heart failure (HF) and peripheral atherosclerosis 
but prevent the development of abdominal aortic aneurysm (AAA). Excess weight 
can reduce the effectiveness of antioxidant stores in AAAs.
6.4 Neurodegenerative diseases
Neurodegenerative disorders are characterized by ROS activation of microglia 
that act as macrophages in the brain. The latter generate, in these glial cells, reactive 
nitrogenous species including inducible nitric oxide synthase (iNOS) and NADPH 
oxydase (NOX2); the activation of which can lead to a respiratory explosion of 
superoxide flooding the mitochondria and contributing more to neurodegeneration 
[65, 66]. GPx1 has a 10-fold higher activity in glial cells than in any other region of 
the brain. The in vivo administration of GPx1 to dopaminergic neurons decreases 
the toxicity of 6-hydroxydopamine in Parkinson’s disease. By employing a lentivirus-
based system to provide GPx1 to neuroblastoma cells in vitro, Ridet et al. witnessed a 
doubled GPx1 expression that protected the neuroblastoma cells against 6-hydroxy-
dopamine-induced neurotoxicity. Other studies have shown that selenocysteine in 
GPx significantly delays human amyloid-Î2-induced paralysis, which is positively 
correlated with the incidence of Alzheimer’s disease and recovers β-amyloid-induced 
toxicity and reduces the cellular level of EOS, by positively affecting life span and 
age-related pathophysiological alterations [67, 68]. Kainic acid is a neurodegenerative 
drug that induces PN formation in the brain. GPx1 knock-out mice are more resistant 
to kainic acid-induced mortality and seizures than wild-type mice. It is likely that the 
roles of GPx1 in neurodegenerative diseases are specific as appropriate [66, 69].
6.5 Autoimmune diseases
Generally, people infected with HIV have low levels of Se and GPx1 activity. 
Analysis of 75S labeling of Jurkat human T cells revealed four 75S proteins includ-
ing GPx1, GPx4, TR1, and Sep15. Taking into account the function of these sele-
noproteins, we can think that Se influences the pathogenesis of acquired immune 
deficiency syndrome (AIDS) via redox regulation. The possible mechanism is that 
GPx1 protects HIV-infected individuals from the loss of helper T cells by prevent-
ing oxidative-induced apoptosis. HIV replication depends on the activation of 
NF-κB [70].
6.6 Cancers
GPx1 has an impact on signal transmission related to cell death, protein kinase 
phosphorylation, and activation of NF-κB via an oxidant; the anomaly of the 
expression of its activity would be at the base of several diseases notably cancer and 
chronic diseases [71]. It is known that the single nucleotide polymorphism (SNP) 
that alters the sequences of a particular amino acid of 201 amino acids, GPx1, is 
associated with certain diseases including lung, bladder, and breast cancers [72]. 
The cells of cancer patients often have defects in the regulation of proliferation, 
apoptosis, and senescence. DNA analysis of breast and colorectal cancers revealed 
that 36–42% of GPX1 genes lose heterozygosity during tumor formation [73]. 
Azoxymethane treatment of Sec-tRNA[Ser] Sec i6A transgenic mice with reduced 
expression of GPx1 resulted in aberrant crypts in their colon compared to wild-
type mice. It appears that the SNP of the GPx1 Pro198Leu would be influenced by 
modulation of ROS levels and the regulation of carcinogenesis. Additional identifi-
cation of GPx tagSNPs and systematic evaluation of their associations with cancer 
will help to expand the ability to diagnose and treat GPx1-related cancers. The GPx1 
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allelic loss of pathologically normal tissue adjacent to tumors would be an early 
event in cancer progression. Chu et al. suggested a possible protective role of GPx2 
against colon cancer. GPx3 has an antioxidant protective role for proximal kidney 
epithelial cells in patients with kidney disease [74].
6.7 Chronic hepatopathy
Patients with chronic liver diseases have shown that disturbances of antioxidant 
parameters in their blood may be the cause of peroxidative damage to hepato-
cytes. Elevated serum carbonyl protein levels, glutathione, GPx, and glutathione 
reductase activities significantly decreased following increased oxidative stress in 
patients with pulmonary and extra pulmonary tuberculosis [75].
7.  Heath benefits of traditional foods as source of precursors of 
glutathione and glutathione peroxidase
Hepatic GSH level is closely related to nutritional conditions, especially the 
cysteine content of the diet. One of the major determinants of the rate of GSH 
synthesis is the availability of cysteine. Cysteine is derived normally from the diet, 
by protein breakdown and in the liver from methionine via transulfuration [3, 11]. 
Se, incorporated as selenocysteine in GPx, acts in antioxidant defense and thyroid 
hormone formation as a protective agent against cancer, muscle diseases, coronary 
heart disease, and HIV [76]. In the immune system, Se stimulates the formation 
and activity of antibodies to helper T cells, cytotoxic T lymphocytes, and natural 
killer (NK) cells. The Se level drops during oxidative stress. High Se intake may 
be associated with a reduced risk of cancer. The recommended daily intake of Se 
ranges from 60 μg/day for women to 70 μg/day for men. The requirements are 
estimated at 100 μg/kg dry matter and 200 μg/kg for pregnant or lactating women. 
Generally, the dietary intake of Se ranges from 7 to 499 μg/day, with average values 
ranging from 40 to 134 μg/day depending on the country [70, 76, 77]. The reasons 
for the variability of consumption are related in particular to factors that determine 
the availability of selenium in the food chain, including soil pH, organic matter con-
tent, as well as the presence of ions that can form a complex with Se. Se deficiency 
can cause several diseases and even cause reproductive disorders in humans and 
animals [77]. The health benefits of Se have increased considerably since the dis-
covery of diseases associated with polymorphisms in selenoprotein genes. Low Se 
status has been associated with impaired immune function with cognitive decline 
and increased risk of death, while Se supplementation with deficient individuals 
reduces the risk of prostate cancer, lung cancer, colorectal cancer, and bladder [76, 
77]. Daily supplementation with Se at a supra-nutritional dose (200 μg) results 
in significant reductions in mortality associated with total carcinomas of lung, 
prostate, and colon cancers without knowing how Se reduces the risk of cancer and 
if the GPx1 is involved in the action [42]. Several cross-sectional studies have dem-
onstrated the correlation between high Se status and plasma cholesterol. Indeed, 
Se supplementation increases the ratio of total cholesterol to significant HDL 
cholesterol in the plasma, suggesting a potentially beneficial effect on cardiovas-
cular risk supplementation [77]. Prospective studies have provided some evidence 
of beneficial effects of Se on the risk of lung, bladder, colorectal, liver, esophagus, 
cardio-gastric, thyroid, and prostate cancers, but these results are sometimes 
disparate [77]. High Se status was associated with decreased risk of hyperglycemia 
and type 2 diabetes, while other studies also reported that high serum Se concen-
tration favored increased prevalence of diabetes male participants followed over 
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9 years. Discrepant Se status in cancer and diabetes is thought to be associated with 
systemic inflammatory status and insulin resistance [77, 78]. The effects of Se on 
human health are multiple and complex, requiring additional research to maximize 
the benefits and reduce the risks of this powerful trace element. The controversial 
results of studies on Se supplementation based on the plasma concentrations of 
the individuals studied require that selenoprotein polymorphisms may be taken 
into account. At this stage, it should be remembered that supplemental Se intake 
from fortification of foods or supplements would be beneficial to people with low 
status, while those with adequate or high status could be negatively affected and no 
Se supplements would be required [77]. Tissue concentration of GSH is controlled 
by the availability of substrate supplied by the diet, the nutritional effects on GSH 
synthetic enzymes, and nutritional influences on the uptake and efflux mechanisms 
for GSH. Sulfur amino acid and Se contents of the diet regulate tissue GSH con-
centration [79]. Forms of Se in foods are essentially selenomethionine from plant 
sources and selenocysteine from animal sources [47].
Traditional and ethnic foods have already existed for a long time and have cultural 
and traditional values. Ethnic foods are defined as those edibles that are eaten and 
prepared by groups of people who share a common religion, language, culture, or 
heritage. Of course, many ethnic foods are prepared using traditional foods and vice 
versa [80]. Traditional foods consist of vegetables, fruits, nuts, seeds, yams, mush-
rooms, herbal teas, meat, fish, insects, etc. The flora of the Democratic Republic of 
Congo is rich in plant resources with high nutritional values and powerful medicinal 
properties [81, 82]. Some of traditional foods could be considered as a source of pre-
cursors of GSH and GPx by their amino acid and Se contents. Mbemba et al. studied 
traditional foods from Bandundu areas of DRC and listed some edible vegetables, 
mushrooms, nuts, and roots that showed high nutritional value [83]. Amino acid 
content of certain traditional foods was interesting about the presence of consider-
able quantity of cysteine and methionine considered such as precursor amino acids 
of glutathione. Salacia pynaerti, Gouania longipetala, Dewevrea bilabiata, Phytolacca 
dodecandra and Solanum macrocarpon were the traditional vegetables identified which 
are rich in methionine and Alternanthera sessilis, Gnetum africanum, Justicia sp., Olax 
subscorpioides, and Salacia pynaerti and rich in cysteine. Some mushrooms were 
equally identified which are rich in cysteine: Auricularia delicate, Cookeina sulcipes, 
Gymnopilus sp., Lentinus squarrosulus, Pilocratera engleriana, Pleutorus tuber-regium, 
Shizophyllum commune, and Oudemansiella canarii [83]. Regarding Se, the literature 
indicates that the animal-derived foods tend to be a better dietary of these micro-
nutrients. Seafoods and organ meats are the richest food sources of selenium [84]. 
Preliminary studies on mineral composition of Congolese traditional foods showed 
that edible insects are the excellent sources of Se (unpublished data). Edible insects 
are known to be excellent sources of mineral micronutrients [85, 86]. Other sources of 
Se include cereals, grains, and dairy products [84]. Selenium concentrations in plant-
based foods vary widely by geographic location. For this, Brazil nuts (Bertholletia 
excelsa, H.B.K.) have the highest selenium concentration of all edible nuts and are 
considered one of the most selenium concentrated food sources [87, 88].
8. Conclusion
The glutathione system plays important biological roles, including the defense 
of cellular tissues against reactive oxygen and nitrogen species, as well as main-
taining the redox status and detoxification of cells. GPx, the main enzyme in the 
antioxidant line, is characterized by eight isomorphs whose activities are localized 
in the various subcellular organelles. During aging, the GSH system in general and 
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the GPx family in particular undergo modifications that promote the production 
of oxidative stress resulting in disturbances in metabolic regulation, damage of 
cellular constituents accompanied by cardiovascular follow-up, neurodegenera-
tion, and cancers. In this evolution, GPx may be a parameter contributing to the 
identification of subclinical asymptomatic cardiometabolic disorders and their 
repair, since its decrease favors atherosclerotic diseases. GPx deficiency results in 
direct tissue damage and activation of age-related NF-κB inflammatory pathways, 
which is associated with aging. Data accumulates to bind alteration or abnormality 
of GPx1 expression toward the etiology of cancer, cardiovascular diseases, neurode-
generation, autoimmune disease, and diabetes. The involvement of the GSH system 
and GPxs in various diseases, especially those of the elderly, is obvious. However, 
at this stage, there is a need for a thorough study to better elucidate the mechanism 
of GPx1 in the pathogenesis and potential applications of GPx1 manipulation in the 
treatment of these disorders.
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